Experiences of and outcomes for Blackpool adults enrolled in the ADDER programme who are treated with buprenorphine prolonged-release injection (Buvidal) opioid substitution therapy
Project: Research
| Status | Finished |
|---|
| Effective start/end date | 1/01/22 → 31/01/25 |
|---|
- NIHR: £21,444.56
- NIHR: £205,682.44
